Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
02/2007
02/20/2007US7179355 Electrochemical cell
02/20/2007US7178719 Facilitating user interaction
02/20/2007US7178416 Radio frequency identification (RFID) test information control and tracking system
02/20/2007US7178415 Dual-opening sample containers, fluid sampling device and method of using same
02/20/2007CA2407158C Multiple frequency grain moisture sensor for combines
02/20/2007CA2289979C Methods of modulating immune coagulation
02/20/2007CA2286680C Detachable-element assay device
02/20/2007CA2267919C Process for the production of analytical devices
02/20/2007CA2228520C Borate storage buffer and sample diluent
02/20/2007CA2176660C Washing a slide at different locations
02/18/2007CA2556456A1 Method of regulation of bacterial persister status
02/15/2007WO2007019546A2 System, device, and methods for simulating surgical wound debridements
02/15/2007WO2007019527A2 Optical sensor and methods for measuring molecular binding interactions
02/15/2007WO2007019410A2 Mammalian obestatin receptors
02/15/2007WO2007019395A1 Method for distinguishing electrochemical sensors
02/15/2007WO2007019385A2 Predictive methods for cancer chemotherapy
02/15/2007WO2007019371A2 Injection fluid leakage collection system and method
02/15/2007WO2007019289A1 Meter having multi-level user interface
02/15/2007WO2007019276A2 Quantitative detection of lead in water
02/15/2007WO2007019273A2 Phosphorylation of tau by abl
02/15/2007WO2007019244A2 Continuous range hydrogen sensor
02/15/2007WO2007019062A2 Zinc finger binding domains for cnn
02/15/2007WO2007018872A1 Label-free high throughput biomolecular screening system and method
02/15/2007WO2007018843A2 Methods and compositions for diagnosis and treatment of influenza
02/15/2007WO2007018760A2 Preparation of plastic supports for biochips
02/15/2007WO2007018647A2 Multifunctional nanostructures, methods of synthesizing thereof, and methods of use thereof
02/15/2007WO2007018556A2 Method for detection and decontamination of antigens by nanoparticle-raman spectroscopy
02/15/2007WO2007018551A2 External modification of composite organic inorganic nanoclusters
02/15/2007WO2007018550A2 Compositions and methods for the detection of hiv-1/hiv-2 infection
02/15/2007WO2007018438A1 Method of differentiating epithelial cells
02/15/2007WO2007018434A1 A method and apparatus for measuring the water conductivity and water volume fraction of a multiphase mixture containing water
02/15/2007WO2007018327A1 An additive scoring method for modified polypeptide
02/15/2007WO2007018320A1 Agent for prevention of graft loss, and screening method for the agent
02/15/2007WO2007018315A1 Protein probe for use in detection of interaction between the protein and other molecule
02/15/2007WO2007018309A1 Method for evaluating compound using molecule on the rb pathway as index and molecular diagnostic method
02/15/2007WO2007018307A1 Phosphoadenylyl sulfate reductase gene and use thereof
02/15/2007WO2007018238A1 Method of screening apoptosis accelerating compound or anti-apoptotic compound and method of determining malignancy of neurodegenerative disease
02/15/2007WO2007018225A1 Method of staining substance having phosphate group
02/15/2007WO2007017965A1 Method of monitoring underground infiltration of carbon dioxide gas
02/15/2007WO2007017916A2 Qualitative assay of extra-virgin olive oils
02/15/2007WO2007017915A2 Use of common ϝ chain cytokines for the visualization, isolation and genetic modification of memory t lymphocytes.
02/15/2007WO2007017701A1 Fingerprint analysis using mass spectrometry
02/15/2007WO2007017678A1 Pyrazolo[1,5-a] pyrimidine compounds and pharmaceutical compositions containing them
02/15/2007WO2007017663A1 Ultrasonic document inspection system
02/15/2007WO2007017648A1 Assay reading device with display
02/15/2007WO2007017556A1 Method for detecting autoantibodies formed in rheumatoid arthritis
02/15/2007WO2007017540A1 Novel biotin reagent, methods of preparing and labelling same and uses thereof
02/15/2007WO2007017383A1 Method and device for operating a state sensor for liquids
02/15/2007WO2007017067A2 Modulators of the melted protein and uses thereof
02/15/2007WO2007017065A2 Angiogenesis inhibition based upon icam 1 or junb expression levels
02/15/2007WO2007016938A2 Methods for diagnosing colon cancer and streptococcus bovis proteins for use in the method
02/15/2007WO2007016912A1 Test system for detecting salmonella
02/15/2007WO2007016866A1 Devices for analyte assays and methods of use
02/15/2007WO2007016763A1 Peptides targeted to protein kinase c isoforms and uses thereof
02/15/2007WO2007016740A1 Water analysis using a photoelectrochemical method
02/15/2007WO2007016716A1 Method for diagnosing tumors by measuring the level of apolipoprotein a-iv
02/15/2007WO2006129828A3 Target substance capturing molecule
02/15/2007WO2006129110A3 Assay
02/15/2007WO2006129054A8 Devices and methods for quantification of liquids in gas-condensate wells
02/15/2007WO2006128163A3 Transgenic alzheimer's mouse model vectors and uses thereof
02/15/2007WO2006125954A3 Water monitoring system
02/15/2007WO2006123122A3 Psk- i and its modulators for the treatment/diagnosis of cancer
02/15/2007WO2006122791A3 Tirc7 as marker for detecting early immune activation
02/15/2007WO2006119942A3 Use of antibody-ligand binding to characterise diseases
02/15/2007WO2006116005A3 Stabilization of cardiac troponin
02/15/2007WO2006113731A9 Bone marrow-derived neurogenic cells and uses thereof
02/15/2007WO2006113727A3 Fluidic structures including meandering and wide channels
02/15/2007WO2006113721A3 Auto-calibration label and methods of forming the same
02/15/2007WO2006107312A8 Nanosensors
02/15/2007WO2006103083B1 System and method for coding information on a biosensor test strip
02/15/2007WO2006094724A3 Screening method, process for purifying of non-diffusible a-beta oligomers, selective antibodies against said non-diffusible a-beta oligomers and a process for manufacturing of said antibodies
02/15/2007WO2006092584A3 Radioisotope labelled biological compositions, and their use in accelerator mass spectrometry
02/15/2007WO2006085972A9 Compositions and processes for the extraction and detection of microbial atp
02/15/2007WO2006084109A3 Salivary protease assays for identifying increased risk of preterm delivery induced by premature rupture of fetal membranes
02/15/2007WO2006082304A3 Novel peptides which interact with anti-apoptotic members of the family of bcl-2 proteins and use thereof
02/15/2007WO2006078503A3 Compositions for modulation of parp and methods for screening for same
02/15/2007WO2006052975A3 Tumor association of mdl-1 and methods
02/15/2007WO2006045004A3 System and method for obtaining, storing, and processing immunologic information of individuals and populations
02/15/2007WO2006025850A3 Method of detecting coliform bacteria from reflected light
02/15/2007WO2006014509A3 Quantitative pcr data analysis system (qdas)
02/15/2007WO2005117270A3 Mass spectrometry with selective ion filtration by digital thresholding
02/15/2007WO2005116264A3 A blood test to monitor the genetic changes of progressive cancer using immunomagnetic enrichment and fluorescence in situ hybridization (fish)
02/15/2007WO2005113059A3 Disruption of the processing of the viral capsid-spacer peptide 1 protein
02/15/2007WO2005100999A3 Functional immunohistochemical cell cycle analysis as a prognostic indicator for cancer
02/15/2007WO2004011607A3 Reagent and method for determination of a substance using an immunoaggregator
02/15/2007US20070039072 Functional and hyperfunctional siRNA
02/15/2007US20070039062 Goodpasture's syndrome model mouse
02/15/2007US20070038384 Devices and assays for monitoring/measuring cellular dynamics to create subject profiles from primary cells
02/15/2007US20070038379 Method and apparatus for predicting structure of transmembrane proteins
02/15/2007US20070038235 Method and apparatus for penetrating tissue
02/15/2007US20070038053 Signal processing for measurement of physiological analytes
02/15/2007US20070037984 Biphenyl derivatives
02/15/2007US20070037967 conjugated by bridging molecules to proteins or polypeptides, reporter groups or cytotoxic agents; cancer
02/15/2007US20070037855 Compounds for inhibiting beta-amyloid production and methods of identifying the compounds
02/15/2007US20070037741 Novel compositions and methods for the treatment of immune related disease
02/15/2007US20070037736 Therapeutic composition comprising the KAL protein and use of the KAL protein for the treatment of retinal, renal, neuronal and neural injury
02/15/2007US20070037297 Highly-sensitive magnetic marker for use in immunoreaction measurement
02/15/2007US20070037296 Contacting the sample in an absorbent matrix with guaiaconic acid and an oxidizing agent, producing an indicator of the presence of hemoglobin and detecting the indicator; contacting with a specific binding partner for hemoglobin in a chromatographic material and detecting binding
02/15/2007US20070037295 Method for preparing a sample
02/15/2007US20070037289 Measuring abosrption after adding developer solution (oxalic acid); second measurement follows addition of sodium molybdate and amino-napthol sulfonic acid